- Home
- TLIH vs MRSN Comparison
TLIH vs MRSN Comparison
Compare TLIH & MRSN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TLIH
- MRSN
- Stock Information
- Founded
- TLIH 1998
- MRSN 2001
- Country
- TLIH Singapore
- MRSN United States
- Employees
- TLIH N/A
- MRSN N/A
- Industry
- TLIH
- MRSN Biotechnology: Pharmaceutical Preparations
- Sector
- TLIH
- MRSN Health Care
- Exchange
- TLIH Nasdaq
- MRSN Nasdaq
- Market Cap
- TLIH 29.1M
- MRSN 32.9M
- IPO Year
- TLIH 2025
- MRSN 2017
- Fundamental
- Price
- TLIH $0.62
- MRSN $6.08
- Analyst Decision
- TLIH
- MRSN Strong Buy
- Analyst Count
- TLIH 0
- MRSN 5
- Target Price
- TLIH N/A
- MRSN $143.75
- AVG Volume (30 Days)
- TLIH 1.2M
- MRSN 118.1K
- Earning Date
- TLIH 01-01-0001
- MRSN 08-13-2025
- Dividend Yield
- TLIH N/A
- MRSN N/A
- EPS Growth
- TLIH N/A
- MRSN N/A
- EPS
- TLIH 0.05
- MRSN N/A
- Revenue
- TLIH $42,862,063.00
- MRSN $34,006,000.00
- Revenue This Year
- TLIH N/A
- MRSN N/A
- Revenue Next Year
- TLIH N/A
- MRSN $1.03
- P/E Ratio
- TLIH $12.59
- MRSN N/A
- Revenue Growth
- TLIH N/A
- MRSN N/A
- 52 Week Low
- TLIH $0.55
- MRSN $5.85
- 52 Week High
- TLIH $7.00
- MRSN $70.75
- Technical
- Relative Strength Index (RSI)
- TLIH N/A
- MRSN 36.53
- Support Level
- TLIH N/A
- MRSN $5.85
- Resistance Level
- TLIH N/A
- MRSN $7.05
- Average True Range (ATR)
- TLIH 0.00
- MRSN 0.47
- MACD
- TLIH 0.00
- MRSN -0.13
- Stochastic Oscillator
- TLIH 0.00
- MRSN 8.93
About TLIH Ten-League International Holdings Limited Ordinary Shares
Ten-League International Holdings Ltd is a Singapore-based provider of turnkey project solutions. Its business consists of sales of heavy equipment and parts, heavy equipment rental and provision of engineering consultancy services to port, construction, civil engineering and underground foundation industries. It currently conducts its operations through its wholly-owned subsidiaries. The equipment it provides is organized into four categories based on their functions and application scenarios, namely, foundation equipment, hoist equipment, excavation equipment and port machinery. The company operates in Singapore and Other International Countries.
About MRSN Mersana Therapeutics Inc.
Mersana Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing antibody-drug conjugates (ADCs) that offer a clinically meaningful benefit for cancer patients with unmet needs. The Company's next-generation ADC platforms include Dolasynthen, which delivers a proprietary auristatin payload, and Immunosynthen, which delivers a proprietary stimulator of interferon genes (STING) agonist payload. Its pipeline includes Emi-Le (XMT-1660), XMT-2056, XMT-2068, and XMT-2175.